In vivo evaluation of a porous hydroxyapatite/poly-DL-lactide composite for bone tissue engineering.
As reported previously, a porous composite of uncalcined hydroxyapatite (u-HA) and poly-DL-lactide (PDLLA) showed excellent osteoconductivity and biodegradability as a bone substitute in rabbit model. In this study, to investigate the usefulness of this composite as a scaffold loaded with cells, we estimated whether this material showed osteogenesis on implantation to extraosseous site. On loading with syngeneic bone marrow cells and implantation into rat dorsal subcutaneous tissue, osteogenesis with enchondral ossification was seen both on and in the material at 3 weeks after implantation. The osteogenesis in the u-HA/PDLLA had progressed, and newly formed bone tissue was found in the material by 6 weeks. To investigate the osteoinductive properties of the material, we implanted this porous composite material into extraosseous canine dorsal muscle. At 8 weeks, osteogenesis was seen in the pores of the material. Newly formed bone could be observed adjacent to the material. In addition, cuboidal osteoblasts adjacent to the newly formed bone were evident. Neither cartilage nor chondrocytes were found. These results might indicate that the material induced osteogenesis by intramembranous ossification. Conversely, similar porous PDLLA did not induce osteogenesis during the observation period. Therefore, porous HA/PDLLA, which has osteoconductive and osteoinductive properties, might be a useful material for use as a bone substitute and cellular scaffold.
Hasegawa
Shin
S
Department of Orthopaedic Surgery, Graduate School of Medicine, Kyoto University, 54 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto 606-8507, Japan. shinhase@kuhp.kyoto-u.ac.jp
Neo
Masashi
M
Tamura
Jiro
J
Fujibayashi
Shunsuke
S
Takemoto
Mitsuru
M
Shikinami
Yasuo
Y
Okazaki
Kenshi
K
Nakamura
Takashi
T
D000818:Animals; D001842:Bone and Bones / Q000166:cytology / Q000187:drug effects* / Q000648:ultrastructure; D002113:Calcification, Physiologic / Q000187:drug effects; D004285:Dogs; D017886:Durapatite / Q000494:pharmacology*; D008297:Male; D008855:Microscopy, Electron, Scanning; D009132:Muscles / Q000187:drug effects; D011091:Polyesters / Q000494:pharmacology*; D016062:Porosity; D019736:Prostheses and Implants; D051381:Rats; D011917:Rats, Inbred Lew; D023822:Tissue Engineering
D011091:Polyesters; C033616:poly(lactide); D017886:Durapatite